Overall, our findings suggest that the hypoxia-related genes, including NDRG1, HK2, and PLOD2, can be controlled by inhibiting STAT3, and this strategy is a novel therapeutic option that may effectively reduce the progression of cervical cancer. This evidence concerns the gene NDRG1 and cervical cancer.